Wells Fargo & Company »

Impact Biomedical shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Impact Biomedical (IBO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Impact Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Impact Biomedical held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Impact Biomedical by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $168 253 0.67
2025-06-30 $19 29 0.66
2025-03-31 $895 1.0k 0.87
2024-12-31 $42 29 1.45
2024-09-30 $58 29 2.00

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Impact Biomedical

Vanguard Group
BlackRock
Geode Capital Management
Two Sigma Investments
Two Sigma Securities
Susquehanna International
State Street Corporation
Mason & Associates
UBS Group
Tower Research Capital
Wells Fargo & Company
Newbridge Financial Services Group
FMR
CWM
Signature Resources Capital Management

View all funds holding Impact Biomedical